Medical specialists from Italy tagged as investigators in clinical trials studying Lymphoma
Total 467 results
-
Francesco Zaja, Prof.Seen in:
- Trieste, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) - SC Ematologia
- Udine, ASUI Integrata di Udine, Clinica Ematologia
Trials:- NCT02858258 (Principal Investigator)
- NCT04882475 (Principal Investigator)
Conditions: -
Francesco ZallioSeen in:
- AL, Alessandria, Presidio Ospedaliero Civile Santi Antonio e Biagio
Trials:- NCT04662255 (Principal Investigator)
Conditions: -
Franco Locatelli, MD PhDSeen in:
- Roma, IRCCS Ospedale Pediatrico Bambino Gesù
- Roma, Ospedale Pediatrico Bambino Gesù
- Rome, Ospedale Pediatrico Bambino Gesù
- Rome, Ospedale Pediatrico Bambino Gesù, Sapienza, University of Rome
Trials:- NCT01949129 (Principal Investigator)
- NCT05298995 (Principal Investigator)
- NCT06064903 (Principal Investigator)
- NCT06080191 (Principal Investigator)
- NCT04787263 (Principal Investigator)
- NCT03373097 (Principal Investigator)
Conditions:- Acute Lymphoblastic Leukaemia;
- High Grade Glioma;
- Medulloblastoma, Childhood;
- Diffuse Intrinsic Pontine Glioma;
- Diffuse Midline Glioma;
- Embryonal Tumor;
- Brain Tumor Adult;
- Brain Tumor, Pediatric;
- T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma;
- B-cell Acute Lymphoblastic Leukemia;
- Acute Lymphoblastic Leukemia;
- Diffuse Large B Cell Lymphoma;
- Primary Mediastinal Lymphoma;
- Sarcoma;
- Osteosarcoma;
- Ewing Sarcoma;
- Neuroblastoma;
- Neuroblastoma Recurrent;
- GD2-positive Solid Tumors
-
Franco Narni, Prof.Seen in:
- Modena, Università di Modena e Reggio Emilia Policlinico - COM Centro Oncologico Modenese, Dipartimento di Oncologia ed Ematologia
Trials:- NCT02858258 (Principal Investigator)
Conditions: -
Gabriele Pozzato, MDSeen in:
- Trieste, Ospedale Riuniti
Trials:- NCT01009970 (Principal Investigator)
Conditions: -
Gabriella Pinotti, MDSeen in:
- Varese, Ospedale Di Circolo E Fondazione Macchi
Trials:- NCT01009970 (Principal Investigator)
Conditions: -
Gabriella Tomei, MDSeen in:
- Frosinone, Frosinone - Presidio Ospedaliero F. Spaziani - UOC Ematologia
Trials:- NCT04442412 (Principal Investigator)
Conditions: -
Gennaro DanieleSeen in:
- Other, Rome, Policlinico Universitario Agostino Gemelli
- Rome, Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica
Trials:- NCT04254107 (Principal Investigator)
- NCT05882734 (Principal Investigator)
Conditions:- Cervical Cancer;
- Ovarian Cancer;
- Peripheral T-cell Lymphoma;
- Bladder Cancer;
- Triple Negative Breast Cancer;
- Non-small Cell Lung Cancer;
- Head and Neck Squamous Cell Carcinoma;
- Gastric Carcinoma;
- Classical Hodgkin Lymphoma;
- Diffuse Large B-cell Lymphoma;
- Cutaneous Melanoma;
- Gastroesophageal Junction Carcinoma;
- Non-Small Cell Lung Cancer
-
Gerardo MusuracaSeen in:
- Emilia-Romagna, Meldola, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
- Forli-Cesena, Meldola, Instituto Scientifico Romagnolo
- Forlì-Cesena, Meldola, IRCCS Istituto Scientifico Romagnolo Per Lo Studio e La Cura Dei Tumori "Dino Amadori" - IRST
- Forlì-Cesena, Meldola, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
- Meldola (FC), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Ematologia
- Meldola, Ematologia - Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.)
- Meldola, IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L., Ematologia
- Meldola, IRCCS Istituto Scientifico Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - IRST
- Meldola, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
- Meldola, Meldola, IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI
Trials:- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT06097364 (Principal Investigator)
- NCT02858258 (Principal Investigator)
- NCT04600804 (Principal Investigator)
- NCT03495960 (Principal Investigator)
- NCT05816850 (Principal Investigator)
-
Giacomo Loseto, MDSeen in:
- Bari, IRCCS Istituto Tumori Giovanni Paolo II, U.O.C Ematologia
- Bari, U.O.C. Ematologia - IRCCS Istituto Tumori Giovanni Paolo II
Trials:- NCT05966233 (Principal Investigator)
- NCT06113081 (Principal Investigator)
-
Gianluca GaidanoSeen in:
- Novara, AOU Maggiore della Carità - Università del Piemonte Orientale, S.C.D.U Ematologia
- Novara, AOU Maggiore della Carità SCDU Ematologia
- Novara, AOU Maggiore della Carità di Novara
- Novara, AOU Maggiore della Carità di Novara - SCDU Ematologia
- Novara, Azienda Ospedale Maggiore Della Carita
- Novara, Azienda Ospedaliera Universitaria Maggiore della Carita di Novara
- Novara, Ospedale Maggiore di Novara
- Novara, S.C.D.U. Ematologia - DIMECS e Dipartimento Oncologico - Università del Piemonte Orientale Amedeo Avogadro
- Novara, Università del Piemonte Orientale - Novara
Trials:- NCT04965493 (Principal Investigator)
- NCT05023980 (Principal Investigator)
- NCT02390869 (Principal Investigator)
- NCT03190525 (Principal Investigator)
- NCT02744768 (Principal Investigator)
- NCT04604067 (Principal Investigator)
- NCT04442412 (Principal Investigator)
- NCT04442022 (Principal Investigator)
- NCT02858258 (Principal Investigator)
- NCT03731234 (Principal Investigator)
-
Gianluigi RedaSeen in:
- MI, Milan, Fondazione IRCCS - Cà Granda Ospedale Maggiore Policlinico
- Milano, Fondazione IRCCS - Cà Granda - Ospedale Maggiore Policlinico
- Milano, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
- Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Milano, Ospedale Maggiore Policlinico - Fondazione IRCCS Ca' Granda - Ematologia
Trials:- NCT05254743 (Principal Investigator)
- NCT05176691 (Principal Investigator)
- NCT05058404 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04333524 (Principal Investigator)
Conditions:- Chronic Lymphocytic Leukemia;
- Leukemia, B-cell;
- Small Lymphocytic Lymphoma;
- Leukemia, Lymphocytic;
- Follicular Lymphoma;
- Waldenstrom Macroglobulinemia;
- Lymphoplasmacytic Lymphoma;
- NHL;
- DLBCL;
- Richter Syndrome;
- CLL/SLL;
- MCL;
- MZL;
- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma
-
Gini GuidoSeen in:
- Ancona, Clinica di Ematologia - A.O.U. Ospedali Riuniti
Trials:- NCT05524298 (Principal Investigator)
Conditions: -
Gioacchino CataniaSeen in:
- Alessandria, Azienda Ospedaliera Nazionale Santi Antonio e Biagio e Cesare Arrigo
- IT, Alessandria, A.O. SS. Antonio e Biagio e Cesare Arrigo, S.C. Ematologia
Trials:- NCT05254743 (Principal Investigator)
- NCT06070961 (Principal Investigator)
-
Giorgia SaporiniSeen in:
- Milan, Ospedale Maggiore Policlinico
Trials:- NCT05886478 (Principal Investigator)
Conditions: -
Giorgina Specchia, MDSeen in:
- Bari, AOU Policlinico Consorziale - U.O. Ematologia con Trapianto
- Bari, Universita Di Bari
Trials:- NCT01009970 (Principal Investigator)
- NCT03552003 (Principal Investigator)
Conditions: -
Giorgio La Nasa, MDSeen in:
- Cagliari, PO "R.Binaghi" - CTMO
Trials:- NCT00598624 (Principal Investigator)
-
Giovanna Leonardi, MDSeen in:
- Modena, Azienda Ospedaliero Universitaria Di Modena, S.C. Ematologia
Trials:- NCT05929222 (Principal Investigator)
Conditions: -
Giovanni Bertoldero, MDSeen in:
- Venezia, Mirano, USLL13 - Dipartimento di Scienze Mediche UOC di Oncologia ed Ematologia Oncologica
Trials:- NCT05058404 (Principal Investigator)
Conditions: -
Giovanni Partesotti, MDSeen in:
- Modena, Sassuolo, Nuovo Ospedale Di Sassuolo S.P.A.
Trials:- NCT01990144 (Principal Investigator)
Conditions: -
Giovanni Pizzolo, PhDSeen in:
- Verona, Policlinico GB Rossi
Trials:- NCT00882011 (Principal Investigator)
Conditions: -
Giovanni Quarta, MDSeen in:
- Brindisi, Stabilimento "Perrino"
Trials:- NCT01990144 (Principal Investigator)
Conditions:
Clinical Trials on Lymphoma
-
Novartis PharmaceuticalsBristol-Myers SquibbRecruitingNon-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone LymphomaUnited States, Germany, Italy, Korea, Republic of, Spain, Singapore, China, Japan, Australia
-
Marcela V. Maus, M.D.,Ph.D.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Refractory Non-Hodgkin Lymphoma | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | Non-hodgkin Lymphoma | High-grade B-cell Lymphoma | Grade 3b Follicular Lymphoma | Relapsed Non-Hodgkin LymphomaUnited States
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell... and other conditionsUnited States
-
BioNova Pharmaceuticals (Shanghai) LTD.TerminatedFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell LymphomaChina
-
SymBio PharmaceuticalsCompletedFollicular Lymphoma | Non-Hodgkin's Lymphoma | Lymphoma, Large Cell | Diffuse, Mantle Cell Lymphoma, Lymphoma | Large B-Cell, DiffuseJapan, Korea, Republic of
-
Tessa TherapeuticsActive, not recruitingAnaplastic Large Cell Lymphoma | Diffuse Large B Cell Lymphoma | Peripheral T Cell Lymphoma | Extranodal NK/T-cell Lymphoma | Primary Mediastinal Large B-Cell Lymphoma (PMBCL)United States
-
Royal Marsden NHS Foundation TrustUnknownMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United Kingdom
-
AmgenCompletedLymphoma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma | Diffuse Large Cell Lymphoma | Low Grade Lymphoma
-
University of WashingtonAstraZenecaRecruitingB-Cell Non-Hodgkin Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Follicular Lymphoma to Diffuse...United States